Your browser doesn't support javascript.
loading
Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
Zubelzu, Maider; Morera-Herreras, Teresa; Irastorza, Gorka; Gómez-Esteban, Juan Carlos; Murueta-Goyena, Ane.
Afiliação
  • Zubelzu M; Department of Pharmacology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.
  • Morera-Herreras T; Department of Pharmacology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. Electronic address: teresa.morera@ehu.eus.
  • Irastorza G; Department of Pharmacology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Gómez-Esteban JC; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain; Department of Neurology, Cruces University Hospital, Osakidetza, Barakaldo, Bizkaia, Spain.
  • Murueta-Goyena A; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Neurosciences, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
Parkinsonism Relat Disord ; 99: 107-115, 2022 06.
Article em En | MEDLINE | ID: mdl-35717321

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article